Aerpio Therapeutics

1 follower


Aerpio Therapeutics, abiotechnology company,develops new small molecules and monoclonal antibodies for the treatment of vascular disease.

Industries

Employees

11-50

Links

Org chart

Joseph Gardner
President and Founder

Joseph Gardner

Collapse
Brandi Soldo
Vice-President, Toxicology
Mitchell Brigell
Consultant, VP Clinical